InMed Pharmaceuticals Inc (INM) — Net Asset Quality Index
InMed Pharmaceuticals Inc (INM) has a Net Asset Quality Index of 35.5% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $3.03 Billion minus total liabilities of $1.96 Billion yields net assets of $1.08 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read how much debt does InMed Pharmaceuticals Inc carry for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
InMed Pharmaceuticals Inc Net Asset Quality Index Over Time (2001–2026)
This chart shows how InMed Pharmaceuticals Inc's Net Asset Quality Index has evolved across 26 annual periods from 2001 to 2026. As of June 2026, the index stands at 35.5%, representing net assets of $1.08 Billion against total assets of $3.03 Billion USD. For live market cap and overall valuation, see INM market cap overview.
Annual Net Asset Quality Index for InMed Pharmaceuticals Inc (2001–2026)
The table below presents the year-by-year Net Asset Quality Index for InMed Pharmaceuticals Inc from 2001 to 2026, covering 26 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check INM strategic asset allocation to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2026 | 35.5% | $1.08 Billion | $3.03 Billion | $1.96 Billion | ▼ -50.8 pp |
| 2025 | 86.2% | $18.30 Million | $21.23 Million | $2.92 Million | ▲ +8.4 pp |
| 2024 | 77.9% | $12.59 Million | $16.17 Million | $3.58 Million | ▼ -7.8 pp |
| 2023 | 85.7% | $16.02 Million | $18.69 Million | $2.67 Million | ▲ +14.7 pp |
| 2022 | 71.0% | $11.69 Million | $16.46 Million | $4.78 Million | ▼ -4.4 pp |
| 2021 | 75.4% | $9.12 Million | $12.10 Million | $2.97 Million | ▲ +0.1 pp |
| 2020 | 75.3% | $5.88 Million | $7.80 Million | $1.92 Million | ▼ -16.8 pp |
| 2019 | 92.1% | $13.88 Million | $15.07 Million | $1.19 Million | ▼ -4.6 pp |
| 2018 | 96.7% | $20.62 Million | $21.34 Million | $713.02K | ▲ +1.1 pp |
| 2017 | 95.6% | $6.13 Million | $6.41 Million | $284.24K | ▲ +31.3 pp |
| 2016 | 64.3% | $820.48K | $1.28 Million | $456.17K | ▼ -31.1 pp |
| 2015 | 95.3% | $1.28 Million | $1.34 Million | $62.51K | ▼ -0.3 pp |
| 2014 | 95.6% | $1.52 Million | $1.59 Million | $70.11K | ▲ +961.5 pp |
| 2013 | -865.9% | $-44.11K | $5.09K | $49.20K | ▼ -871.7 pp |
| 2012 | 5.7% | $2.72K | $47.31K | $44.59K | ▼ -75.7 pp |
| 2011 | 81.4% | $202.29K | $248.50K | $46.20K | ▲ +910.8 pp |
| 2010 | -829.4% | $-1.20 Million | $144.72K | $1.35 Million | ▲ +3218.5 pp |
| 2009 | -4047.9% | $-1.03 Million | $25.42K | $1.05 Million | ▼ -4037.9 pp |
| 2008 | -10.1% | $-138.98K | $1.38 Million | $1.52 Million | ▲ +225.6 pp |
| 2007 | -235.7% | $-950.42K | $403.26K | $1.35 Million | ▼ -161.2 pp |
| 2006 | -74.5% | $-485.38K | $651.70K | $1.14 Million | ▼ -6.4 pp |
| 2005 | -68.1% | $-670.63K | $984.74K | $1.66 Million | ▼ -25.0 pp |
| 2004 | -43.1% | $-235.55K | $545.89K | $781.44K | ▼ -63.9 pp |
| 2003 | 20.8% | $241.85K | $1.16 Million | $921.99K | ▼ -73.8 pp |
| 2002 | 94.5% | $1.29 Million | $1.36 Million | $74.45K | ▲ +5.1 pp |
| 2001 | 89.4% | $4.18 Million | $4.67 Million | $493.02K | — |